Diagnostic Imaging Market Global Report 2026

The diagnostic imaging market size has grown steadily in recent years. It will grow from $34.43 billion in 2025 to $36 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, growing adoption of advanced imaging technologies, expansion of hospital diagnostic capabilities, and increasing demand for accurate disease diagnosis services.

The diagnostic imaging market size is expected to see steady growth in the next few years. It will grow to $43.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing aging population globally, rising demand for personalized medical solutions, growing adoption of portable imaging technologies, expansion of preventive healthcare programs, and increasing healthcare spending in emerging economies. Major trends in the forecast period include rising demand for early disease detection technologies, growing adoption of portable diagnostic imaging systems, increasing preference for minimally invasive diagnostic procedures, expansion of imaging utilization in chronic disease management, and growing demand for high-resolution and multi-modality imaging solutions.

The rising burden of infectious diseases is expected to drive the growth of the diagnostic imaging market going forward. Infectious diseases are illnesses caused by pathogens such as viruses, bacteria, fungi, or parasites that can spread between individuals or through environmental exposure. The increasing burden of infectious diseases is primarily driven by declining global immunization coverage, as gaps in vaccination programs allow highly contagious pathogens to circulate and trigger large-scale outbreaks across multiple regions. The growing incidence of infectious diseases increases the need for advanced imaging modalities such as chest X-rays and CT scans, which are essential tools for detecting pulmonary complications, organ involvement, and disease progression in affected patients. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising burden of infectious diseases is driving the growth of the diagnostic imaging market.

Key companies operating in the diagnostic imaging market are focusing on developing advanced imaging platforms, such as helium-efficient MRI systems, to improve sustainability, enhance operational efficiency, and expand access to diagnostic services. Helium-efficient MRI systems refer to advanced magnetic resonance imaging technologies designed to significantly reduce helium consumption while maintaining high-quality imaging performance and system reliability. In February 2025, GE HealthCare, a US-based medical technology company, launched its Freelium, a magnetic resonance imaging (MRI) platform to support sustainability goals and improve imaging accessibility. The platform uses less than 1% of the helium required by conventional MRI systems, reducing dependence on scarce resources while enabling efficient installation and reliable imaging performance across healthcare facilities. The Freelium platform also features a lightweight system architecture, advanced AI-enabled imaging capabilities, remote service support, and faster workflow integration to enhance diagnostic precision and operational productivity.

In April 2024, GE HealthCare, a US-based health technology company, acquired MIM Software Inc. for an undisclosed amount. With this acquisition, GE HealthCare aims to enhance its precision care approach by integrating advanced imaging analysis, AI-powered image interpretation, and automated workflows to improve clinical efficiency and patient care across multiple therapeutic areas. MIM Software Inc. is a US-based developer of vendor-neutral medical imaging software solutions used in radiology, nuclear medicine, molecular imaging, theranostics, and radiation oncology.

Major companies operating in the diagnostic imaging market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Canon Inc., Hologic Inc., Mindray Medical International Ltd., Carestream Health Inc., Konica Minolta Inc., Shimadzu Corporation, Agfa-Gevaert N.V., Varex Imaging Corporation, Guerbet SA, United Imaging Healthcare Co. Ltd., Neusoft Medical Systems Co. Ltd., Esaote S.p.A., Samsung HME America, RadNet Inc., Allengers Medical Systems Limited, CurveBeam AI Ltd., Planmed Oy, JSC Amico, SternMed GmbH, Koning Health Inc.

North America was the dominant region in the diagnostic imaging market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the diagnostic imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostic imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic imaging market consists of revenues earned by entities by providing services such as radiology services, imaging diagnostics, teleradiology services, image interpretation services, medical imaging reporting, and diagnostic scan services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic imaging market also includes sales of MRI scanners, CT scanners, X-ray machines, ultrasound machines, PET scanners, SPECT scanners, and mammography systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The diagnostic imaging market research report is one of a series of new reports that provides diagnostic imaging market statistics, including diagnostic imaging industry global market size, regional shares, competitors with a diagnostic imaging market share, detailed diagnostic imaging market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic imaging industry. This diagnostic imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.